(Reuters) - Arca Biopharma Inc said the U.S. Food and Drug Administration granted its experimental drug orphan drug status as a potential treatment for viral hemorrhagic fever after exposure to the Ebola virus.
via Reuters: Health News Read More Here..
No comments:
Post a Comment